Contact Us
Click here to contact Felicity Thomas,editor.
May 14, 2014
Phase I data Phase I study data offer hope for NK patients Recombinant human Nerve Growth Factor (rhNGF) may offer hope for patients with neurotrophic keratitis (NK), according to researchers in Milan, Italy, who presented preliminary data from a Phase I study at the annual meeting of the Association for Research in Vision and Ophthalmology. More...
Logistical regression analysis Hyperglycaemia significantly correlates with ROP The correlation between hyperglycaemia and retinopathy of prematurity (ROP) is significant, according to logistical regression analysis of gestational age and birth weight data in a recent study. More...
Refractory glaucoma Valve and implant compared for refractory glaucoma Patients with refractory glaucoma in whom a proprietary glaucoma was placed needed significantly less adjunctive medication to experience success in treatment compared with those who received a proprietary glaucoma valve. However, fewer of those in the latter group had serious postoperative complications, according to 3-year outcomes. More...
Ranibizumab leading the anti-VEGF evolution
Considerations and new perspectives in anti-VEGF therapy.
Read more:
Choosing and using the AcrySof IQ ReSTOR IOL family
Customized options for individual patients.
Read more:
The Safety of anti-VEGF Therapy Under the microscope, in trials and in clinical practice. Read more:
